APA (7th ed.) Citation

Gharzai, L. A., Morris, E., Suresh, K., Nguyen-Tân, P. F., Rosenthal, D. I., Gillison, M. L., . . . Le, Q. (2024). Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: An individual patient data meta-analysis. Lancet Oncology, 25(3), 366. https://doi.org/10.1016/S1470-2045(24)00016-0

Chicago Style (17th ed.) Citation

Gharzai, Laila A., et al. "Surrogate Endpoints in Clinical Trials of P16-positive Squamous Cell Carcinoma of the Oropharynx: An Individual Patient Data Meta-analysis." Lancet Oncology 25, no. 3 (2024): 366. https://doi.org/10.1016/S1470-2045(24)00016-0.

MLA (9th ed.) Citation

Gharzai, Laila A., et al. "Surrogate Endpoints in Clinical Trials of P16-positive Squamous Cell Carcinoma of the Oropharynx: An Individual Patient Data Meta-analysis." Lancet Oncology, vol. 25, no. 3, 2024, p. 366, https://doi.org/10.1016/S1470-2045(24)00016-0.